Eversept Partners, LP Abbott Laboratories Transaction History

Eversept Partners, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $2.08 Million - $2.51 Million	-31,400 Closed	0 $0
Q4 2018 Nov 08, 2023	SELL	$65.56 - $74.27 $2.86 Million - $3.25 Million	-43,700 Reduced 58.19%	31,400 $2.27 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $2.86 Million - $3.25 Million	-43,700 Reduced 58.19%	31,400 $2.27 Million
Q3 2018 Nov 08, 2023	BUY	$60.81 - $73.36 $1.78 Million - $2.14 Million	29,200 Added 63.62%	75,100 $5.51 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.78 Million - $2.14 Million	29,200 Added 63.62%	75,100 $5.51 Million
Q2 2018 Nov 08, 2023	SELL	$57.57 - $63.54 $115,140 - $127,080	-2,000 Reduced 4.18%	45,900 $2.8 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $115,140 - $127,080	-2,000 Reduced 4.18%	45,900 $2.8 Million
Q1 2018 Nov 08, 2023	BUY	$56.27 - $63.62 $2.7 Million - $3.05 Million	47,900 New	47,900 $2.87 Billion
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $2.7 Million - $3.05 Million	47,900 New	47,900 $2.87 Million

3,208

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.